🏅 SBE Honors ChemsynBio Research

We are proud to share that Prof. Benjamí Oller-Salvia has been awarded the Enrique Pérez-Payá-Prospera Biotech & BCN Peptides Prize 2026 by the Spanish Biophysical Society (SBE) in recognition of the ChemsynBio Group's pioneering work on conditionally active protein therapeutics and brain-targeting peptides. The award recognizes the trajectory and achievements of outstanding researchers under the age of 40 who are advancing the field of biophysics in Spain.

The Spanish Biophysical Society (SBE) promotes excellence in biophysics and fosters collaboration between researchers working at the interface of biology, chemistry, physics, and medicine.

Reflecting on this recognition, Prof. Oller-Salvia highlighted the collective effort behind the achievement:

“This award reflects the work of the ChemsynBio Group at IQS–Ramon Llull University, whose talent, dedication, and collaborative spirit have made it possible.”

The award was presented during the European South Atlantic Biophysics Congress (ESAB 2026), held in Montpellier, France, one of the leading biophysics meetings in Europe. The congress brought together researchers from across the continent to discuss cutting-edge advances in structural biology, biomolecular interactions, therapeutic design, imaging, and quantitative approaches to understanding living systems.

As part of the meeting, Prof. Oller-Salvia delivered an invited lecture showcasing the ChemsynBio Group's latest advances in the design of smart protein therapeutics and peptide-based technologies for targeted delivery to the brain. The opportunity to share our research with the international biophysics community underscores the growing impact of interdisciplinary approaches that combine chemistry, biology, and physics to address unmet medical challenges. 🚀🧬

Congratulations to all current and former members of the ChemsynBio Group whose creativity, teamwork, and perseverance continue to drive innovative research with the potential to improve patients' lives. 👏

Click me